Goldman Sachs Group Inc Liquidia Corp Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 778,276 shares of LQDA stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
778,276
Previous 260,467 198.8%
Holding current value
$12.8 Million
Previous $2.6 Million 251.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$9.82 - $11.8 $5.08 Million - $6.11 Million
517,809 Added 198.8%
778,276 $9.15 Million
Q3 2024

Nov 14, 2024
BUY
$8.9 - $14.11 $835,683 - $1.32 Million
93,897 Added 56.37%
260,467 $2.6 Million
Q2 2024

Aug 13, 2024
SELL
$11.96 - $15.71 $1.17 Million - $1.54 Million
-97,891 Reduced 37.02%
166,570 $2 Million
Q1 2024

May 15, 2024
SELL
$11.35 - $16.73 $1.91 Million - $2.81 Million
-167,895 Reduced 38.83%
264,461 $3.9 Million
Q4 2023

Feb 13, 2024
BUY
$5.77 - $12.19 $1.81 Million - $3.83 Million
313,975 Added 265.22%
432,356 $5.2 Million
Q3 2023

May 14, 2024
SELL
$6.27 - $8.15 $1.97 Million - $2.56 Million
-313,975 Reduced 72.62%
118,381 $750,000
Q3 2023

Nov 14, 2023
SELL
$6.27 - $8.15 $137,482 - $178,705
-21,927 Reduced 15.63%
118,381 $750,000
Q2 2023

May 14, 2024
SELL
$6.63 - $9.9 $172,194 - $257,122
-25,972 Reduced 15.62%
140,308 $1.1 Million
Q2 2023

Aug 14, 2023
SELL
$6.63 - $9.9 $172,194 - $257,122
-25,972 Reduced 15.62%
140,308 $1.1 Million
Q1 2023

May 14, 2024
SELL
$5.72 - $7.91 $194,640 - $269,161
-34,028 Reduced 16.99%
166,280 $1.15 Million
Q1 2023

May 11, 2023
SELL
$5.72 - $7.91 $194,640 - $269,161
-34,028 Reduced 16.99%
166,280 $1.15 Million
Q4 2022

May 14, 2024
SELL
$4.68 - $6.54 $553,606 - $773,629
-118,292 Reduced 37.13%
200,308 $1.28 Million
Q4 2022

Feb 13, 2023
SELL
$4.68 - $6.54 $553,606 - $773,629
-118,292 Reduced 37.13%
200,308 $1.28 Million
Q3 2022

May 14, 2024
BUY
$3.73 - $8.39 $977,651 - $2.2 Million
262,105 Added 463.94%
318,600 $1.73 Million
Q3 2022

Nov 10, 2022
BUY
$3.73 - $8.39 $977,651 - $2.2 Million
262,105 Added 463.94%
318,600 $1.73 Million
Q2 2022

May 14, 2024
SELL
$3.37 - $7.55 $1.27 Million - $2.84 Million
-375,861 Reduced 86.93%
56,495 $246,000
Q2 2022

Aug 15, 2022
SELL
$3.37 - $7.55 $200,511 - $449,217
-59,499 Reduced 51.29%
56,495 $246,000
Q1 2022

May 16, 2022
BUY
$5.14 - $7.38 $502,455 - $721,424
97,754 Added 535.93%
115,994 $832,000
Q4 2021

Feb 14, 2022
BUY
$2.71 - $5.17 $6,929 - $13,219
2,557 Added 16.3%
18,240 $89,000
Q3 2021

Nov 10, 2021
BUY
$2.28 - $2.95 $35,757 - $46,264
15,683 New
15,683 $43,000

Others Institutions Holding LQDA

# of Institutions
188
Shares Held
44.8M
Call Options Held
1.22M
Put Options Held
1.09M
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.06B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email